3-iodobenzylguanidine has been researched along with sodium iodate in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Babich, J; Boyd, M; Fullerton, NE; Kirk, D; Mairs, RJ; Pimlott, SL; Ross, SC; Zalutsky, MR | 1 |
1 other study(ies) available for 3-iodobenzylguanidine and sodium iodate
Article | Year |
---|---|
Comparison of radiohaloanalogues of meta-iodobenzylguanidine (MIBG) for a combined gene- and targeted radiotherapy approach to bladder carcinoma.
Topics: 3-Iodobenzylguanidine; Alpha Particles; Astatine; Beta Particles; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; Dose-Response Relationship, Radiation; Genetic Therapy; Humans; Iodates; Iodine Radioisotopes; Norepinephrine Plasma Membrane Transport Proteins; Radiopharmaceuticals; Structure-Activity Relationship; Symporters; Tumor Cells, Cultured; Urinary Bladder Neoplasms | 2005 |